Drug-induced hypoglycemia: a disproportionality analysis of the FAERS database

References

• Yale JF, Paty B, Senior PA, et al. Hypoglycemia. Can J Diabetes. 2018;42(Suppl 1):S104–S108. doi: 10.1016/j.jcjd.2017.10.010
   PubMed Web of Science ®Google Scholar
• Graveling AJ, Frier BM. Hypoglycaemia: an overview. Prim Care Diabetes. 2009;3(3):131–139. doi: 10.1016/j.pcd.2009.08.007
   PubMed Web of Science ®Google Scholar
• Weant KA, Clendening AM, Bush JS. A case report of hypoglycemia following a tramadol overdose in a non-diabetic patient. J Pharm Pract. 2022;35(4):661–663. doi: 10.1177/08971900211000701
   PubMed Web of Science ®Google Scholar
• Malboosbaf R, Hatami N, Maghsoomi Z. Methadone-induced hypoglycemia: a case report. J Diabetes Investig. 2023;14(1):145–146. doi: 10.1111/jdi.13919
   PubMed Web of Science ®Google Scholar
• Ibrahim FA, Rashid F, Hussain AA, et al. Rasagiline-induced severe recurrent hypoglycemia in a young woman without diabetes: a case report. J Med Case Rep. 2017;11(1):29. doi: 10.1186/s13256-017-1202-x
   PubMedGoogle Scholar
• Mehrpour O, Saeedi F, Hoyte C, et al. Distinguishing characteristics of exposure to biguanide and sulfonylurea anti-diabetic medications in the United States. Am J Emerg Med. 2022;6(56):171–177. doi: 10.1016/j.ajem.2022.03.023
   Google Scholar
• Mehrpour O, Saeedi F, Nakhaee S, et al. Comparison of decision tree with common machine learning models for prediction of biguanide and sulfonylurea poisoning in the United States: an analysis of the national poison data system. BMC Med Inform Decis Mak. 2023;23(1):60. doi: 10.1186/s12911-022-02095-y
   PubMed Web of Science ®Google Scholar
• Philis-Tsimikas A, Klonoff DC, Khunti K, et al. Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: the randomised, head-to-head CONCLUDE trial. Diabetologia. 2020;63(4):698–710. doi: 10.1007/s00125-019-05080-9
   PubMed Web of Science ®Google Scholar
• Battelino T, Tehranchi R, Bailey T, et al. Dasiglucagon, a next-generation ready-to-use glucagon analog, for treatment of severe hypoglycemia in children and adolescents with type 1 diabetes: results of a phase 3, randomized controlled trial. Pediatr Diabetes. 2021;22(5):734–741. doi: 10.1111/pedi.13220
   PubMed Web of Science ®Google Scholar
• Wu Z, Zhou P, He N, et al. Drug-induced torsades de pointes: disproportionality analysis of the United States Food and drug Administration adverse event reporting system. Front Cardiovasc Med. 2022;9:966331. doi: 10.3389/fcvm.2022.966331
   PubMed Web of Science ®Google Scholar
• Alomar M, Tawfiq AM, Hassan N, et al. Post marketing surveillance of suspected adverse drug reactions through spontaneous reporting: current status, challenges and the future. Ther Adv Drug Saf. 2020;11:11. doi: 10.1177/2042098620938595
   Web of Science ®Google Scholar
• Bergamaschi F, Fumagalli M, Mannarino S, et al. Severe hypoglycemia in children treated with nadolol: a case report and FDA adverse event reporting system (FAERS) database analysis. Int J Clin Pharmacol Ther. 2021;59(4):333–340. doi: 10.5414/CP203786
   PubMed Web of Science ®Google Scholar
• Juba KM, van Manen RP, Fellows SE. A review of the Food and drug Administration adverse event reporting system for tramadol-related hypoglycemia. Ann Pharmacother. 2020;54(3):247–253. doi: 10.1177/1060028019885643
   PubMed Web of Science ®Google Scholar
• Zhao Z, Tang Y, Hu Y, et al. Hypoglycemia following the use of glucagon-like peptide-1 receptor agonists: a real-world analysis of post-marketing surveillance data. Ann Transl Med. 2021;9(18):1482. doi: 10.21037/atm-21-4162
   PubMed Web of Science ®Google Scholar
• Duggirala HJ, Tonning JM, Smith E, et al. Use of data mining at the Food and drug Administration. J Am Med Inform Assoc. 2016;23(2):428–434. doi: 10.1093/jamia/ocv063
   PubMed Web of Science ®Google Scholar
• Böhm R, Höcker J, Cascorbi I, et al. OpenVigil–free eyeballs on AERS pharmacovigilance data. Nat Biotechnol. 2012;30(2):137–138. doi: 10.1038/nbt.2113
   PubMed Web of Science ®Google Scholar
• Böhm R, Bulin C, Waetzig V, et al. Pharmacovigilance-based drug repurposing: the search for inverse signals via OpenVigil identifies putative drugs against viral respiratory infections. Br J Clin Pharmacol. 2021;87(11):4421–4431. doi: 10.1111/bcp.14868
   PubMed Web of Science ®Google Scholar
• Tian X, Zheng S, Wang J, et al. Cardiac disorder-related adverse events for aryl hydrocarbon receptor agonists: a safety review. Expert Opin Drug Saf. 2022;21(12):1505–1510. doi: 10.1080/14740338.2022.2078301
   PubMed Web of Science ®Google Scholar
• Caster O, Aoki Y, Gattepaille LM, et al. Disproportionality analysis for pharmacovigilance signal detection in small databases or subsets: recommendations for limiting false-positive associations. Drug Saf. 2020;43(5):479–487. doi: 10.1007/s40264-020-00911-w
   PubMed Web of Science ®Google Scholar
• Ooba N, Kubota K. Selected control events and reporting odds ratio in signal detection methodology. Pharmacoepidemiol Drug Saf. 2010;19(11):1159–1165. doi: 10.1002/pds.2014
   PubMed Web of Science ®Google Scholar
• Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf. 2001;10(6):483–486. doi: 10.1002/pds.677
   PubMed Web of Science ®Google Scholar
• Shariff A, Sridhar SB, Bittar HR, et al. Frequency and predisposing factors for drug-induced hypoglycemia in patients with type-2 diabetes mellitus. J Res Pharm Pract. 2019;8(2):64–68. doi: 10.4103/jrpp.JRPP_18_58
   PubMed Web of Science ®Google Scholar
• Silbert R, Salcido-Montenegro A, Rodriguez-Gutierrez R, et al. Hypoglycemia Among patients with type 2 diabetes: epidemiology, risk factors, and prevention strategies. Curr Diab Rep. 2018;18(8):53. doi: 10.1007/s11892-018-1018-0
   PubMed Web of Science ®Google Scholar
• Leese GP, Wang J, Broomhall J, et al. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care. 2003;26(4):1176–1180. doi: 10.2337/diacare.26.4.1176
   PubMed Web of Science ®Google Scholar
• Murad MH, Coto-Yglesias F, Wang AT, et al. Clinical review: drug-induced hypoglycemia: a systematic review. J Clin Endocrinol Metab. 2009;94(3):741–745. doi: 10.1210/jc.2008-1416
   PubMed Web of Science ®Google Scholar
• Laing SP, Swerdlow AJ, Slater SD, et al. The British diabetic association cohort study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet Med. 1999;16(6):466–471. doi: 10.1046/j.1464-5491.1999.00076.x
   PubMed Web of Science ®Google Scholar
• Yeh JS, Sung SH, Huang HM, et al. Hypoglycemia and risk of vascular events and mortality: a systematic review and meta-analysis. Acta Diabetol. 2016;53(3):377–392. doi: 10.1007/s00592-015-0803-3
   PubMed Web of Science ®Google Scholar
• Chinese Diabetes Society. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition). Chin J Diabetes Mellitus. 2021;13(4): 315–409. doi: 10.3760/cma.j.cn115791-20210221-00095
   Google Scholar
• Mannucci E, Candido R, Monache LD, et al. Italian guidelines for the treatment of type 2 diabetes. Acta Diabetol. 2022;59(5):579–622. doi: 10.1007/s00592-022-01857-4
   PubMed Web of Science ®Google Scholar
• Davies MJ, Aroda VR, Collins BS, et al. Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD). Diabetologia. 2022;65(12):1925–1966. doi: 10.1007/s00125-022-05787-2
   PubMed Web of Science ®Google Scholar
• Levine GN, Bates ER, Bittl JA, et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American heart association Task Force on clinical practice guidelines. J Am Coll Cardiol. 2016;68(10):1082–1115. doi: 10.1016/j.jacc.2016.03.513
   PubMed Web of Science ®Google Scholar
• Ibanez B, James S, Agewall S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119–177. doi: 10.1093/eurheartj/ehx393
   PubMed Web of Science ®Google Scholar
• Kobayakawa N, Sawaki D, Otani Y, et al. A case of severe diabetes mellitus occurred during management of heart failure with carvedilol and furosemide. Cardiovasc Drugs Ther. 2003;17(3):295. doi: 10.1023/a:1026253013891
   PubMedGoogle Scholar
• Feng LF, Chen XH, Li DX, et al. Reye syndrome and sudden death symptoms after oral administration of nimesulide due to upper respiratory tract infection in a boy. Chin J Contemp Pediatr. 2018;20(11):944–949. doi: 10.7499/j.issn.1008-8830.2018.11.013
   Google Scholar
• Amrith BP, Jain P, Chaudhari KA, et al. Severe hypoglycemia with trastuzumab: An unseen adverse event. South Asian J Cancer. 2019;8(3):149. doi: 10.4103/sajc.sajc_400_18
   PubMed Web of Science ®Google Scholar
• Zonta ZJ, Flotats X, Magrí A. Estimation of parameter uncertainty for an activated sludge model using Bayesian inference: a comparison with the frequentist method. Environ Technol. 2014;35(13–16):1618–1629. doi: 10.1080/09593330.2013.876450
   PubMed Web of Science ®Google Scholar
• Aliyu I, Kyari F, Ibrahim Z. Hypoglycemia in a child with tramadol poisoning. Saudi J Med Med Sci. 2016;4(1):35–37. doi: 10.4103/1658-631X.170892
   PubMed Web of Science ®Google Scholar
• Nakhaee S, Brent J, Hoyte C, et al. The effect of tramadol on blood glucose concentrations: a systematic review. Expert Rev Clin Pharmacol. 2020;13(5):531–543. doi: 10.1080/17512433.2020.1756773
   PubMed Web of Science ®Google Scholar